KALIMATE Calcium polystyrene sulfonate powder For Nephritis

聚苯乙烯磺酸钙散剂

Generic name: calcium polystyrene sulfonate powder
Chinese Pinyin: JuBenYiXiHuangSuanGaiSanJi
English name: Calcium Polystyrene Sulfonate Powder
Product name: Klimt
Ingredients: Calcium polystyrene sulfonate.
Properties: This product is yellowish white to light yellow powder; odorless and tasteless.
Indications: Hyperkalemia caused by acute and chronic renal dysfunction.
Specification: 5g*9 bags/box
Usage and Dosage: Oral, 20g per day for adults, 5-10g per day for children, divided into 1-3 times. Suspend the powder in 150ml water when taking it, and take it immediately after stirring.
Adverse reactions: 1. Digestive system: constipation, nausea, vomiting, stomach discomfort, loss of appetite, and sorbitol can alleviate constipation. 2. Electrolytes: Hypokalemia may occur, pay attention to observe the condition, and measure the serum dielectric regularly.
Contraindications: Patients with hypokalemia and hypercalcemia are forbidden. The following patients are prohibited from taking sorbitol together: those with fructose intolerance, patients with 1,6-=fructose phosphate deficiency, methanol poisoning, etc.
Note: Not yet clear
Drug interactions: Drug interactions may occur if used with other drugs at the same time. Please consult your physician or pharmacist for details.
Pharmacology and Toxicology: Used for clinical adjuvant therapy of acute and chronic renal insufficiency and renal failure, especially suitable for nephritis, renal failure and major surgical operations, trauma, crush injuries, burns, severe infections, massive blood loss, etc. Kemia. Detailed product description: 1. In order to prevent overdose, the concentration of serum potassium and serum calcium should be monitored at the same time of administration, and the drug should be stopped when the serum potassium concentration is lower than 4-5mEq/L. 2. Patients with hyperparathyroidism and multiple myeloma should be used with caution. 3. Due to the effect of this product in reducing serum potassium, it may enhance the poisoning effect of digitalis, so it should be administered with caution when combined. 4. In severe cases of potassium poisoning (>6.5mEq/L), accompanied by ECG changes, it is not sufficient to use this product alone, and other potassium-lowering measures should be applied. 5. Patients with high levels of glucoside may have life-threatening adverse events, especially for patients with ventricular tachycardia. 6. When taking this product, you should use a low-potassium and high-calorie diet and control acidosis.
Storage: sealed.
Packing: 5g*9 bags/box.
Validity period: 24 months
Approval number: National Medicine Standard J20120048
Company Name: Kowa Co., Ltd.